The Asian Scientist 100
Lisa Ng
Institution
A*STAR Infectious Diseases Labs and A*STAR Biomedical Research Council
Country
Singapore
Field
Biomedical Sciences
Ng won the President’s Science Award 2025 for her pioneering contributions to viral infection immunology and advancing global pandemic management through groundbreaking research on arboviruses, particularly Chikungunya.
AWARDS
- President’s Science Award 2025
Related articles
Loss of X Chromosome May Reduce Chances Of Natural Pregnancy
As more women delay parenthood, researchers are searching for better ways to assess fertility. A new study points to loss of the X chromosome as a potential indicator of declining reproductive potential.
Wastewater Monitoring Can Predicts Flu Outbreaks Sooner Than Clinical Data
A study from Japan demonstrates that wastewater monitoring can accurately forecast influenza A and B outbreaks up to a week earlier than traditional surveillance.
This Norovirus Breakthrough Could Accelerate Vaccine Development
Japanese researchers have developed a reverse genetics system that enables the generation and study of infectious noroviruses without the use of cultured cells.
Champions Of Science
This International Women’s Day, we are highlighting some powerful women researchers who are redefining their fields.
Meet Balanophora, The Parasitic Plant That Barely Qualifies As A Plant
Researchers have traced how Balanophora evolved an extreme parasitic lifestyle—shrinking its plastid genome and, in some species, abandoning sexual reproduction entirely.
City Life Forces Two Rival Hornets To Coexist By Changing What They Eat
In non-urban areas, the two species consumed similar prey, reflecting their natural competitive relationship.
On The Evolution Of Orchids That Never Bloom
A rare occurrence in the wild, exclusive self-pollination is an evolutionary strategy that may lead to extinction.
Streamlining Robust Cell Line Development
Novel bioprocessing technologies can enable the development of robust, high-yield cell lines, supporting advances in biomedical research and pharmaceutical innovation.
MiRXES Launches New Manufacturing and Research Capabilities
With a slew of new capabilities and a collaborative project, biotechnology company, MiRXES, hopes to contribute to Singapore’s vision of early cancer screening.